Amphastar Pharmaceuticals Net Profit Margin 2012-2024 | AMPH

Amphastar Pharmaceuticals net profit margin from 2012 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Amphastar Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-09-30 $0.72B $0.16B 21.72%
2024-06-30 $0.71B $0.17B 23.28%
2024-03-31 $0.68B $0.15B 22.75%
2023-12-31 $0.65B $0.14B 21.24%
2023-09-30 $0.60B $0.14B 22.43%
2023-06-30 $0.54B $0.10B 18.85%
2023-03-31 $0.52B $0.09B 17.95%
2022-12-31 $0.50B $0.09B 18.27%
2022-09-30 $0.48B $0.08B 15.91%
2022-06-30 $0.48B $0.09B 19.12%
2022-03-31 $0.46B $0.08B 18.02%
2021-12-31 $0.44B $0.06B 14.38%
2021-09-30 $0.41B $0.04B 8.96%
2021-06-30 $0.38B $0.01B 2.86%
2021-03-31 $0.37B $0.00B 0.82%
2020-12-31 $0.35B $0.00B 0.57%
2020-09-30 $0.34B $0.01B 2.08%
2020-06-30 $0.33B $0.00B 1.20%
2020-03-31 $0.33B $0.05B 15.90%
2019-12-31 $0.32B $0.05B 15.22%
2019-09-30 $0.33B $0.05B 15.81%
2019-06-30 $0.33B $0.05B 16.31%
2019-03-31 $0.32B $0.00B 0.63%
2018-12-31 $0.30B $-0.01B -2.03%
2018-09-30 $0.27B $-0.01B -2.64%
2018-06-30 $0.25B $-0.01B -3.64%
2018-03-31 $0.24B $-0.00B -1.66%
2017-12-31 $0.24B $0.00B 1.67%
2017-09-30 $0.24B 0 0.00%
2017-06-30 $0.25B $0.00B 1.60%
2017-03-31 $0.25B $0.01B 3.56%
2016-12-31 $0.26B $0.01B 3.92%
2016-09-30 $0.27B $0.02B 7.84%
2016-06-30 $0.27B $0.01B 5.22%
2016-03-31 $0.25B 0 0.00%
2015-12-31 $0.25B $-0.00B -1.19%
2015-09-30 $0.23B $-0.01B -6.06%
2015-06-30 $0.23B $-0.02B -7.05%
2015-03-31 $0.22B $-0.01B -4.50%
2014-12-31 $0.21B $-0.01B -5.21%
2014-09-30 $0.21B $-0.01B -2.86%
2014-06-30 $0.21B $-0.00B -0.48%
2014-03-31 $0.22B $0.01B 3.59%
2013-12-31 $0.23B $0.01B 5.22%
2013-09-30 $0.23B $0.01B 6.17%
2013-06-30 $0.23B $0.02B 7.56%
2013-03-31 $0.21B $0.01B 6.64%
2012-12-31 $0.20B $0.02B 8.82%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.186B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.395B 6.36
Dr Reddy's Laboratories (RDY) India $11.853B 22.68
BridgeBio Pharma (BBIO) United States $4.426B 0.00
Bausch Health Cos (BHC) Canada $2.931B 2.13
Supernus Pharmaceuticals (SUPN) United States $2.000B 27.23
Taysha Gene Therapies (TSHA) United States $0.506B 35.29
Personalis (PSNL) United States $0.245B 0.00
Assembly Biosciences (ASMB) United States $0.096B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.006B 0.00
Teligent (TLGT) United States $0.000B 0.00